申请人:Peng Lee F.
公开号:US20110172233A1
公开(公告)日:2011-07-14
The present invention relates to relates to macrocyclic small molecule inhibitors of the Sonic Hedgehog signaling pathway, syntheses thereof, and intermediates thereto. Such small molecule modulators of the Sonic Hedgehog signaling pathway are useful in the treatment of proliferative diseases (e.g., basal cell carcinoma, Gorlin syndrome, medulloblastoma, or pancreatic cancer), pulmonary diseases (e.g., interstitial pnuemonitis or interstitial pulmonary fibrosis), and developmental disorders (e.g., phocomelia or cyclopia). Novel non-natural macrocycles are provided that inhibit Sonic Hedgehog induced-protein transcription.
本发明涉及Sonic Hedgehog信号通路的大环小分子抑制剂、其合成和中间体。这种Sonic Hedgehog信号通路的小分子调节剂在治疗增殖性疾病(例如基底细胞癌、Gorlin综合症、髓母细胞瘤或胰腺癌)、肺部疾病(例如间质性肺炎或间质性肺纤维化)和发育障碍(例如肢体畸形或单眼畸形)中非常有用。提供了新型的非天然大环,可以抑制Sonic Hedgehog诱导的蛋白质转录。